Alkermes Plc (ALKS)
36.95
-0.03
(-0.08%)
USD |
NASDAQ |
May 21, 16:00
36.99
+0.04
(+0.11%)
After-Hours: 19:59
Alkermes Research and Development Expense (TTM) : 349.59M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amarin Corp. Plc | 16.24M |
| Xenon Pharmaceuticals, Inc. | 325.78M |
| Tyra Biosciences, Inc. | 110.89M |
| Spyre Therapeutics, Inc. | 190.44M |
| Agios Pharmaceuticals, Inc. | 342.68M |